Refresh

Jenburkt Pharmaceuticals Ltd. - Research Center

524731 JENBURPH Group (X) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19
Income

Operating income

136.75 123.98 109.29 118.89 122.64
Expenses

Material consumed

33.00 31.43 30.10 33.07 36.26

Manufacturing expenses

1.56 1.24 0.84 1.11 1.39

Personnel expenses

38.81 36.49 32.38 36.51 31.20

Selling expenses

- - - - -

Adminstrative expenses

33.01 27.56 26.13 28.46 28.83

Expenses capitalised

- - - - -

Cost of sales

106.38 96.73 89.45 99.15 97.68

Operating profit

30.37 27.26 19.84 19.74 24.96

Other recurring income

5.12 4.95 4.31 4.22 3.41

Adjusted PBDIT

35.49 32.20 24.15 23.96 28.37

Financial expenses

0.37 0.43 0.47 0.53 0.39

Depreciation

2.26 1.90 2.04 2.30 1.35

Other write offs

- - - - -

Adjusted PBT

32.86 29.87 21.64 21.14 26.63

Tax charges

8.26 7.57 5.14 6.27 6.84

Adjusted PAT

24.61 22.30 16.50 14.87 19.80

Non recurring items

-0.01 - - - -

Other non cash adjustments

- - - - -

Reported net profit

24.60 22.30 16.50 14.87 19.80

Earnigs before appropriation

133.13 113.21 90.91 84.29 73.07

Equity dividend

5.51 4.68 - 10.12 3.32

Preference dividend

- - - - -

Dividend tax

- - - - -

Retained earnings

127.62 108.53 90.91 74.16 69.75
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com